Pharmaceutical Imaging 🏥 and Contrast Agents

Created using ChatSlide

This lecture provides an in-depth overview of Clariscan™, a gadoteric acid-based MRI contrast agent approved in 2013. Key topics include its indications for visualizing brain and spine tissues across all age groups, including neonates, and its standardized dosing protocols. Attendees will gain insights into the agent's safety profile, including boxed warnings, potential adverse reactions, and specific considerations for sensitive populations such as pregnant or lactating women, children, and...